Journal of Atherosclerosis Research
Volume 10, Issue 3 , Pages 283-289, November 1969

In vitro inhibition by metabolic antagonists of incorporation of [32P]phosphate into the major phospholipids of swine coronary and pulmonary arteries*

Received 5 September 1969

Summary 

Incorporation of [32P]phosphate into sphingomyelin, phosphatidyl choline, phosphatidyl serine and phosphatidyl ethanolamine of normal swine arteries was studied in vitro. Choline added to the media increased the specific activity in phosphatidyl choline, whereas ethanolamine had no significant effects. Addition of 2-amino-2-methyl-l-propanol in concentrations from 0.001–0.1 M inhibited incorporation of 32P into all the phospholipid classes; phosphatidyl choline was affected to a somewhat greater extent than the others. Ratios of choline to aminomethylpropanol in the media of 1:1 and 10:1 resulted in partial reversal of the inhibition; the reversal was nearly complete at a ratio of 100:1. The pulmonary artery seemed to be somewhat less sensitive than the coronary artery to inhibition of net phospholipid synthesis by aminomethylpropanol.

Addition of 3-amino-l-propanol, dimethylaminoisopropanol and triethanol-amine in concentrations of 0.001, 0.01 and 0.1 M each resulted in inhibition of [32P]-phosphate incorporation into the phospholipids of the coronary arteries; there was little evidence of specific inhibition of any of the individual phospholipid classes studied.

Key words: Aminomethylpropanol, 3-Aminopropanol, Choline-ethanolamine, Coronary/pulmonary phospholipid synthesis, Dimethyl isopropanol-amine, Phosphatidyl choline, Triethanolamine

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

* This investigation was supported by Grant No. 5R01-HE10172-03 from the National Heart Institute, United States Public Health Service.

PII: S0368-1319(69)80032-3

Journal of Atherosclerosis Research
Volume 10, Issue 3 , Pages 283-289, November 1969